BEAMTREE HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.17 AUD | -2.86% |
|
0.00% | -27.66% |
| Mar. 11 | Beamtree Changes Registered Office; Shares Decline 5% | MT |
| Feb. 13 | Transcript : Beamtree Holdings Limited, H1 2024 Earnings Call, Feb 14, 2024 |
| Sales 2024 * | 27.59M 17.88M | Sales 2025 * | 36.2M 23.46M | Capitalization | 48.87M 31.67M |
|---|---|---|---|---|---|
| Net income 2024 * | -5M -3.24M | Net income 2025 * | -3M -1.94M | EV / Sales 2024 * | 1.66 x |
| Net cash position 2024 * | 2.97M 1.93M | Net cash position 2025 * | 3.21M 2.08M | EV / Sales 2025 * | 1.26 x |
| P/E ratio 2024 * |
-9.98
x | P/E ratio 2025 * |
-15.3
x | Employees | 95 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.91% |
More Fundamentals
* Assessed data
More news
Latest transcript on Beamtree Holdings Limited
| 1 day | -2.86% | ||
| Current month | -20.93% | ||
| 1 month | -19.05% | ||
| 3 months | -24.44% | ||
| 6 months | -17.07% | ||
| Current year | -27.66% |
1 week
0.17
0.18
1 month
0.170.22
Current year
0.170.24
1 year
0.170.33
3 years
0.170.70
5 years
0.090.70
10 years
0.090.70
| Managers | Title | Age | Since |
|---|---|---|---|
Tim Kelsey
CEO | Chief Executive Officer | - | 20-10-05 |
Mark McLellan
DFI | Director of Finance/CFO | - | 22-03-31 |
Stephen Morgan
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Hill
CHM | Chairman | 51 | 18-06-25 |
Brad Lancken
BRD | Director/Board Member | - | 19-10-17 |
Emma Gray
BRD | Director/Board Member | - | 22-11-23 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 0.17 | -2.86% | 72 643 |
| 24-04-22 | 0.175 | +2.94% | 99,001 |
| 24-04-19 | 0.17 | -2.86% | 106,920 |
| 24-04-18 | 0.175 | +2.94% | 1,700 |
| 24-04-17 | 0.17 | 0.00% | 374,978 |
Delayed Quote Australian S.E., April 23, 2024 at 12:17 am EDT
More quotes
Beamtree Holdings Limited is an Australia-based artificial intelligence decision support and data company. The Company provides automation technology and data analytics that support health care providers. The Company's segments include diagnostic technology, clinical decision support, coding assistance and data quality, analytics and knowledge networks. The diagnostic technology segment includes its RippleDown products, which automate decision making in clinical and administrative processes in pathology. Its automation of clinical record coding and data integrity products include its RippleDown and Performance Indicators for Coding Quality coding technologies (PICQ). Its clinical decision support segment includes Ainsoff Deterioration Index, which is a machine learning-based tool that predicts the risk of patient deterioration and alerts clinicians in real time. Its products also include advisory and auditing, Q coding platform, and Relative Indicators for Safety and Quality.
Sector
Software
Calendar
2024-08-20
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.175
AUD
Average target price
0.7
AUD
Spread / Average Target
+300.00%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -27.66% | 32.38M | |
| +8.10% | 2,979B | |
| +2.46% | 78.63B | |
| +2.39% | 77.7B | |
| -12.94% | 53.96B | |
| -16.12% | 50.39B | |
| +26.41% | 46.4B | |
| +12.53% | 38.04B | |
| +53.83% | 33.68B | |
| -11.46% | 23.88B |
- Stock Market
- Equities
- BMT Stock
